Tilfrinib (4f) 4-anilino α-carbolines mediated PTK6 inhibition shows anti-proliferative effects on MCF7, HS-578/T, and BT-549 breast cancer cell lines [108]. This evidence concerns the gene PTK6 and breast carcinoma.